IDEAYA Biosciences (IDYA) Capital Expenditures (2018 - 2026)

IDEAYA Biosciences has disclosed Capital Expenditures across 9 years of filings, most recently posting $967000.0 for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $967000.0, up 47.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 million (up 37.49% YoY), and the FY2025 annual result was $2.4 million, up 60.11% from the prior year.
• Capital Expenditures came in at $967000.0 for Q1 2026 at IDEAYA Biosciences, down from $1.7 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $2.7 million in Q3 2024 to a low of -$3.1 million in Q4 2022.
• The 5-year median for Capital Expenditures is $654000.0 (2025), against an average of $445058.8.
• Across the five-year window, Capital Expenditures slumped 252.27% in 2024 and surged 1070.29% in 2025, its largest moves.
• IDEAYA Biosciences' Capital Expenditures stood at -$3.1 million in 2022, then surged by 127.39% to $838000.0 in 2023, then plunged by 252.27% to -$1.3 million in 2024, then soared by 236.29% to $1.7 million in 2025, then plunged by 44.39% to $967000.0 in 2026.
• The last three Capital Expenditures figures came in at $967000.0 (Q1 2026), $1.7 million (Q4 2025), and -$1.4 million (Q3 2025), per Business Quant data.